New combo therapy targets liver tumors in colorectal cancer patients

NCT ID NCT04595266

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 22 times

Summary

This study tests whether adding a liver-directed treatment (chemoembolization with drug-coated beads) to standard chemotherapy can better shrink liver tumors in people with colorectal cancer that has spread only to the liver. About 48 adults with poor-prognosis liver metastases will be randomly assigned to receive either standard chemo alone or standard chemo plus the liver treatment. The main goal is to see how many patients have significant tumor shrinkage after 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Complejo Hospitalario de Navarra

    Pamplona, Pamplona, Spain

  • H. Univ. Ramón y Cajal

    Madrid, Madrid, 28044, Spain

  • Hospital Clínic

    Barcelona, Barcelona, Spain

  • Hospital Parc Taulí

    Sabadell, Barcelona, Spain

  • Hospital Universitari i Politècnic La Fe

    Valencia, Valencia, 46026, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain

  • Hospital Universitario La Paz

    Madrid, Madrid, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Barcelona, Spain

Conditions

Explore the condition pages connected to this study.